New Zealand - English - Ministry for Primary Industries

elanco new zealand - dinoprost - dinoprost 5 g/litre - endocrine agent (hormone)

United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - dinoprostone 10 mg in 241 mg

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - solution for injection - dinoprostone 10 mg/ml - dinoprostone - dinoprostone - therapeutic termination of pregnancy, missed abortion.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - gel - dinoprostone 0.033 %w/w - dinoprostone - dinoprostone - for labour induction in term and near term pregnant women who have favorable induction features and who have a singleton pregnancy with vertex presentation

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - gel - dinoprostone 0.066 %w/w - dinoprostone - dinoprostone - for labour induction in term and near term pregnant women who have favorable induction features and who have a singleton pregnancy with vertex presentation

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - dinoprostone - pessary - dinoprostone 10 mg - dinoprostone - dinoprostone - initiation and/or continuation of cervical ripening in patients at term, from 38th week of gestation, with bishop score of 6 or less.

United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - dinoprostone 10 mg in 241 mg - cervidil is indicated for the initiation and/or continuation of cervical ripening in pregnant women at or near term in whom there is a medical or obstetrical indication for the induction of labor. cervidil is contraindicated in patients with: - known hypersensitivity to prostaglandins [see adverse reactions (6.2)] - evidence or clinical suspicion of fetal distress where delivery is not imminent - unexplained vaginal bleeding in the current pregnancy - evidence or clinical suspicion of marked cephalopelvic disproportion - conditions for which induction of labor is contraindicated - conditions for which oxytocic drugs are contraindicated - previous cesarean section or other uterine surgery expected to affect uterine integrity (such as myomectomy) - conditions under which prolonged contraction of the uterus may be detrimental to fetal safety - concurrent use with intravenous oxytocic agents [see warnings and precautions (5.4) and drug interactions (7)] - six or more previous term pregnancies risk summary cervidi

United States - English - NLM (National Library of Medicine)

pharmacia and upjohn company llc - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - dinoprostone 0.5 mg in 3 g - prepidil gel is indicated for ripening an unfavorable cervix in pregnant women at or near term with a medical or obstetrical need for labor induction. endocervically administered prepidil gel is not recommended for the following: - cases with a history of cesarean section or major uterine surgery - cases in which cephalopelvic disproportion is present - cases in which there is a history of difficult labor and/or traumatic delivery - grand multiparae with six or more previous term pregnancies cases with non-vertex presentation - cases with hyperactive or hypertonic uterine patterns - cases of fetal distress where delivery is not imminent - in obstetric emergencies where the benefit-to-risk ratio for either the fetus or the mother favors surgical intervention no drug abuse or drug dependence has been seen with the use of prepidil gel.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

techno drugs ltd. - dinoprost - injection - 50 mg/10 ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - dinoprost - unknown - dinoprost prostaglandin active 0.0 - active constituent